Specifically, the PD-1/4-1BB high co-expression group exhibited more active immune responses and immune cell infiltration with cytotoxic effects, indicating a potential relevance in the advancement of new therapeutic approaches targeting the immune system in cervical cancer. This evidence concerns the gene PDCD1 and cervical cancer.